Answers are grounded in this paper and cite their sources.
Given the putative role of PHGDH in cancer, development of inhibitors is required to explore its function. In this context, we established and validated a straightforward enzymatic assay suitable for high-throughput screening and we identified inhibitors with similar chemical scaffolds. Through a convergent pharmacophore approach, we synthesized α-ketothioamides that exhibit interesting in vitro PHGDH inhibition and encouraging cellular results. These novel probes may be used to understand the emerging biology of this metabolic target.
No takes yet. Share an insight, caveat, or question.
Ravez et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: